Bank of Nova Scotia Has $1.19 Million Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Bank of Nova Scotia grew its position in Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 27.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 27,512 shares of the company’s stock after buying an additional 5,843 shares during the period. Bank of Nova Scotia’s holdings in Bath & Body Works were worth $1,187,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. TFO Wealth Partners LLC increased its position in Bath & Body Works by 9,664.7% in the fourth quarter. TFO Wealth Partners LLC now owns 1,660 shares of the company’s stock worth $72,000 after purchasing an additional 1,643 shares during the period. TD Asset Management Inc grew its position in shares of Bath & Body Works by 3.7% during the 4th quarter. TD Asset Management Inc now owns 976,278 shares of the company’s stock worth $42,136,000 after buying an additional 35,261 shares during the period. Nomura Asset Management Co. Ltd. raised its stake in shares of Bath & Body Works by 7.2% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 116,647 shares of the company’s stock worth $5,034,000 after buying an additional 7,867 shares during the last quarter. Advisory Services Network LLC acquired a new position in Bath & Body Works in the fourth quarter valued at approximately $170,000. Finally, Frazier Financial Advisors LLC bought a new position in Bath & Body Works in the fourth quarter valued at approximately $1,618,000. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Trading Down 0.7 %

Shares of NYSE BBWI opened at $45.84 on Friday. The company has a fifty day moving average price of $47.10 and a 200 day moving average price of $44.06. Bath & Body Works, Inc. has a 1-year low of $27.30 and a 1-year high of $52.99. The firm has a market cap of $10.23 billion, a PE ratio of 11.81, a PEG ratio of 1.56 and a beta of 1.90.

Bath & Body Works (NYSE:BBWIGet Free Report) last posted its quarterly earnings data on Tuesday, June 4th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.33 by $0.05. Bath & Body Works had a negative return on equity of 40.00% and a net margin of 11.92%. The company had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.37 billion. During the same period in the prior year, the firm earned $0.33 earnings per share. Bath & Body Works’s revenue for the quarter was down .9% compared to the same quarter last year. Equities research analysts forecast that Bath & Body Works, Inc. will post 3.27 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 21st. Stockholders of record on Friday, June 7th will be issued a $0.20 dividend. The ex-dividend date of this dividend is Friday, June 7th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.75%. Bath & Body Works’s dividend payout ratio (DPR) is presently 20.62%.

Wall Street Analysts Forecast Growth

Several analysts have commented on BBWI shares. TD Cowen upped their target price on shares of Bath & Body Works from $35.00 to $55.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. BMO Capital Markets upped their price objective on Bath & Body Works from $50.00 to $55.00 and gave the company an “outperform” rating in a report on Wednesday. UBS Group raised their target price on Bath & Body Works from $46.00 to $52.00 and gave the stock a “neutral” rating in a report on Monday, March 4th. Deutsche Bank Aktiengesellschaft upped their price target on Bath & Body Works from $53.00 to $57.00 in a research note on Monday, June 3rd. Finally, Wells Fargo & Company lifted their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock an “equal weight” rating in a research note on Wednesday, April 24th. Eight analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, Bath & Body Works currently has an average rating of “Hold” and an average price target of $48.53.

Check Out Our Latest Report on Bath & Body Works

Insider Transactions at Bath & Body Works

In related news, insider Thomas E. Mazurek sold 4,285 shares of the firm’s stock in a transaction on Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total value of $209,493.65. Following the completion of the transaction, the insider now owns 45,992 shares of the company’s stock, valued at $2,248,548.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.27% of the stock is currently owned by insiders.

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Further Reading

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.